Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Lumito

0.94 SEK+6.33 %21/9 17:29
Less than 1K followers

LUMITO

NGM Growth Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+6.33 %
-51.79 %
-64.00 %
-73.40 %
-82.82 %
-97.08 %
-99.59 %
-99.51 %
-99.51 %

Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.

Read more
Market cap
10.99M SEK
Turnover
284.41K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
29/10
2026

Interim report Q3'26

23/2
2027

Annual report '26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-09-21 13:38

Analyst Group: Analyst Group Kommentar Lumitos framgångsrika integration av SCIZYS i ett automatiserat laboratorieflöde hos CliniSciences

Lumito
Regulatory press release2026-09-21 08:30

Lumito visar framgångsrik integration av SCIZYS® i automatiserat laboratorieflöde

Lumito
Regulatory press release2026-09-21 08:30

Lumito demonstrates successful integration of SCIZYS® within automated laboratory workflow

Lumito

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-09-15 16:55

Analyst Group: Analyst Group kommenterar på extern studie som visar nya tillämpningsområden för Lumitos SCIZYS inom immunologisk forskning

Lumito
Regulatory press release2026-09-15 10:25

Extern studie visar nya tillämpningsområden för SCIZYS® inom immunologisk forskning

Lumito
Regulatory press release2026-09-15 10:25

External study demonstrates new application areas for SCIZYS® in immunological research

Lumito
Press release2026-09-01 14:45

Analyst Group: Analyst Group kommenterar Lumitos första order utanför Norden

Lumito
Regulatory press release2026-09-01 10:30

Lumito erhåller första order utanför Norden

Lumito
Regulatory press release2026-09-01 10:30

Lumito receives first order outside the Nordic region

Lumito
Regulatory press release2026-09-01 08:30

Lumito säger upp avtal om mentorskap

Lumito
Regulatory press release2026-09-01 08:30

Lumito terminates mentorship agreement

Lumito
Press release2026-08-25 14:29

Analyst Group: Aktieanalys på Lumito - Kommersiell exekvering i fokus framgent

Lumito
Press release2026-08-20 14:52

Analyst Group: Analyst Group kommenterar Lumitos Q2-rapport

Lumito
Regulatory press release2026-08-20 08:30

Lumito publicerar kvartalsrapport för det andra kvartalet 2026

Lumito
Regulatory press release2026-08-20 08:30

Lumito publishes interim report for the second quarter of 2026

Lumito
Regulatory press release2026-08-18 11:00

Lumito bjuder in till webbinarium i samband med publicering av kvartalsrapport för det andra kvartalet 2026

Lumito
Regulatory press release2026-08-18 11:00

Lumito invites to a webinar in connection with the publication of its second-quarter 2026 report

Lumito
Regulatory press release2026-08-17 13:03

Lumito offentliggör slutlig delregistrering av företrädesemission samt registrering av ersättningsemission

Lumito
Regulatory press release2026-08-10 08:30

Lumitos styrelse beslutar om en riktad nyemission av units till emissionsgaranten i samband med den avslutade företrädesemissionen

Lumito
Regulatory press release2026-08-07 15:30

Lumito offentliggör delregistrering av företrädesemission innebärande registrering av minskning av aktiekapital och ändrad bolagsordning

Lumito